Egetis Therapeutics AB (publ) (STO:EGTX)
5.80
+0.01 (0.17%)
Apr 29, 2026, 5:29 PM CET
Egetis Therapeutics AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -342.5 | -343.6 | -326.9 | -193.8 | -104.5 | Upgrade
|
| Depreciation & Amortization | 3.8 | 3.4 | 3.6 | 2.7 | 2.5 | Upgrade
|
| Other Amortization | 33.7 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 13.4 | 14.7 | 8 | 8.8 | 1.2 | Upgrade
|
| Other Operating Activities | -1.8 | 9 | 6 | -2.1 | -1.1 | Upgrade
|
| Change in Accounts Receivable | -8.6 | 13.4 | -22.9 | -10.7 | 3.1 | Upgrade
|
| Change in Other Net Operating Assets | 35 | 75.2 | 53.8 | 21.6 | -31.3 | Upgrade
|
| Operating Cash Flow | -267 | -227.9 | -278.4 | -173.5 | -130.1 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0.2 | Upgrade
|
| Cash Acquisitions | -1.3 | -1.2 | - | -1.7 | -5 | Upgrade
|
| Sale (Purchase) of Intangibles | -1.5 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | -0.8 | Upgrade
|
| Investing Cash Flow | -2.8 | -1.2 | - | -1.7 | -6 | Upgrade
|
| Long-Term Debt Issued | - | - | 108.8 | - | - | Upgrade
|
| Long-Term Debt Repaid | -31.9 | -10.2 | -5.6 | -9.1 | -8.9 | Upgrade
|
| Net Debt Issued (Repaid) | -31.9 | -10.2 | 103.2 | -9.1 | -8.9 | Upgrade
|
| Issuance of Common Stock | 183.2 | 301.5 | 381.9 | 177.4 | - | Upgrade
|
| Repurchase of Common Stock | - | -1.5 | - | - | - | Upgrade
|
| Other Financing Activities | -11.3 | -18.9 | -26.2 | -12.6 | - | Upgrade
|
| Financing Cash Flow | 140 | 270.9 | 458.9 | 155.7 | -8.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | -5.4 | 5.8 | -4.8 | 3.2 | 1.1 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0.1 | - | - | - | Upgrade
|
| Net Cash Flow | -135.2 | 47.7 | 175.7 | -16.3 | -143.9 | Upgrade
|
| Free Cash Flow | -267 | -227.9 | -278.4 | -173.5 | -130.3 | Upgrade
|
| Free Cash Flow Margin | -427.89% | -494.36% | -483.33% | -767.70% | -341.10% | Upgrade
|
| Free Cash Flow Per Share | -0.71 | -0.73 | -1.07 | -0.89 | -0.72 | Upgrade
|
| Cash Interest Paid | 14.4 | 17.6 | 4.1 | 0.1 | - | Upgrade
|
| Cash Income Tax Paid | 0.5 | 0.3 | 0.1 | - | - | Upgrade
|
| Levered Free Cash Flow | -139.65 | -105.43 | -159.79 | -112.39 | -90.55 | Upgrade
|
| Unlevered Free Cash Flow | -130.65 | -94.43 | -157.16 | -112.33 | -90.43 | Upgrade
|
| Change in Working Capital | 26.4 | 88.6 | 30.9 | 10.9 | -28.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.